Article Text

Download PDFPDF

Pre-exposure prophylaxis acceptability among transgender women in the UK
  1. Ella G Brown1,
  2. Kevin Deane2
  1. 1Barts and The London School of Medicine and Dentistry, London, UK
  2. 2Centre for Global Public Health, Queen Mary University of London, London, UK
  1. Correspondence to Ella G Brown, Barts and The London School of Medicine and Dentistry, London E1 2AD, UK; ella.brown{at}

Statistics from

After years of campaigning and controversy, the Department of Health recently announced that they will begin routine commissioning of pre-exposure prophylaxis (PrEP) in England, meaning that free at the point of access PrEP is available in all regions of the UK. This is an important step forward in the UK’s aim to reach zero transmissions by 2030. Global data have shown that transgender women (TGW) are disproportionately affected by HIV.1 This can be attributed to a plethora of intersecting risk factors and vulnerabilities, many of which stem from the systemic and enacted discrimination, stigma and marginalisation that TGW experience.2 Given their increased risk, PrEP could be a valuable tool for TGW, especially given that risk factors such as involvement in sex work, sexual violence, and diminished sexual agency often preclude condom use.2 However, …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.